Expand Your Med Options With Torisel, Treanda Codes
Published on Mon Mar 23, 2009
Find out which code payers might pair with 189.0. Your fallback for some cancer medications might be J9999 (Not otherwise classified, antineoplastic drugs), but you won't rely on that any longer for Torisel or Treanda intravenous infusions. Each medication now has its own J code, effective for dates of service on or after Jan. 1, 2009. Switch to J9330 for Torisel The FDA approves Torisel (temsirolimus) for injection to treat patients with advanced renal cell carcinoma (189.0, Malignant neoplasm of kidney and other and unspecified urinary organs; kidney, except pelvis). Patients typically receive 25 mg weekly via an IV infusion that takes 30 to 60 minutes (96413, Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug). The new J code you-ll report for Torisel administration is J9330 (Injection, temsirolimus, 1 mg). Because it's a 1 mg-dosage code, you-ll report J9330 for each mg your staff administers. [...]
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
